Trial Profile
A retrospective, observational single-center study evaluating effectiveness of switching treatment from Etanercept (Enbrel) to the Biosimilar Drug, Benepali
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting